ArticleMolecular therapy. Oncology2026

Non-viral targeted integration at the CISH locus enables CAR-NK cell engineering with enhanced anti-tumor activity.

Jiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.